These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 36831683)
1. DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets. Ozair A; Bhat V; Alisch RS; Khosla AA; Kotecha RR; Odia Y; McDermott MW; Ahluwalia MS Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831683 [TBL] [Abstract][Full Text] [Related]
2. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas. Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441 [TBL] [Abstract][Full Text] [Related]
3. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients. Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093 [TBL] [Abstract][Full Text] [Related]
4. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Bady P; Sciuscio D; Diserens AC; Bloch J; van den Bent MJ; Marosi C; Dietrich PY; Weller M; Mariani L; Heppner FL; Mcdonald DR; Lacombe D; Stupp R; Delorenzi M; Hegi ME Acta Neuropathol; 2012 Oct; 124(4):547-60. PubMed ID: 22810491 [TBL] [Abstract][Full Text] [Related]
5. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593 [TBL] [Abstract][Full Text] [Related]
6. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas. Gömöri E; Pál J; Kovács B; Dóczi T Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301 [TBL] [Abstract][Full Text] [Related]
7. The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. Ohka F; Natsume A; Motomura K; Kishida Y; Kondo Y; Abe T; Nakasu Y; Namba H; Wakai K; Fukui T; Momota H; Iwami K; Kinjo S; Ito M; Fujii M; Wakabayashi T PLoS One; 2011; 6(8):e23332. PubMed ID: 21829728 [TBL] [Abstract][Full Text] [Related]
8. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. Paul Y; Mondal B; Patil V; Somasundaram K Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842 [TBL] [Abstract][Full Text] [Related]
10. Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients. Chen X; Yan Y; Zhou J; Huo L; Qian L; Zeng S; Li Z; Wei J; Xu Z; Gong Z Ann Transl Med; 2019 Oct; 7(20):541. PubMed ID: 31807523 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting. Hewer E; Prebil N; Berezowska S; Gutt-Will M; Schucht P; Dettmer MS; Vassella E Virchows Arch; 2017 Nov; 471(5):641-649. PubMed ID: 28823044 [TBL] [Abstract][Full Text] [Related]
12. Glioma epigenetics: From subclassification to novel treatment options. Gusyatiner O; Hegi ME Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066 [TBL] [Abstract][Full Text] [Related]
13. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Wiestler B; Capper D; Hovestadt V; Sill M; Jones DT; Hartmann C; Felsberg J; Platten M; Feiden W; Keyvani K; Pfister SM; Wiestler OD; Meyermann R; Reifenberger G; Pietsch T; von Deimling A; Weller M; Wick W Neuro Oncol; 2014 Dec; 16(12):1630-8. PubMed ID: 25028501 [TBL] [Abstract][Full Text] [Related]
14. Overview of DNA methylation in adult diffuse gliomas. Aoki K; Natsume A Brain Tumor Pathol; 2019 Apr; 36(2):84-91. PubMed ID: 30937703 [TBL] [Abstract][Full Text] [Related]
15. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Wiestler B; Capper D; Sill M; Jones DT; Hovestadt V; Sturm D; Koelsche C; Bertoni A; Schweizer L; Korshunov A; Weiß EK; Schliesser MG; Radbruch A; Herold-Mende C; Roth P; Unterberg A; Hartmann C; Pietsch T; Reifenberger G; Lichter P; Radlwimmer B; Platten M; Pfister SM; von Deimling A; Weller M; Wick W Acta Neuropathol; 2014 Oct; 128(4):561-71. PubMed ID: 25008768 [TBL] [Abstract][Full Text] [Related]
16. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment. Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199 [TBL] [Abstract][Full Text] [Related]
17. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas. Abe H; Natsumeda M; Kanemaru Y; Watanabe J; Tsukamoto Y; Okada M; Yoshimura J; Oishi M; Fujii Y Neurol Med Chir (Tokyo); 2018 Jul; 58(7):290-295. PubMed ID: 29848907 [TBL] [Abstract][Full Text] [Related]
18. The association between Okita Y; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Kinoshita M; Nonaka M; Fujinaka T; Kanemura Y Clin Radiol; 2020 Aug; 75(8):622-628. PubMed ID: 32321646 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation in adult diffuse gliomas. LeBlanc VG; Marra MA Brief Funct Genomics; 2016 Nov; 15(6):491-500. PubMed ID: 27288434 [TBL] [Abstract][Full Text] [Related]
20. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative Unterrainer M; Fleischmann DF; Vettermann F; Ruf V; Kaiser L; Nelwan D; Lindner S; Brendel M; Wenter V; Stöcklein S; Herms J; Milenkovic VM; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1368-1380. PubMed ID: 31486876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]